This is a Validated Antibody Database (VAD) review about mouse F2rl1, based on 9 published articles (read how Labome selects the articles), using F2rl1 antibody in all methods. It is aimed to help Labome visitors find the most suited F2rl1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
F2rl1 synonym: Gpcr11; PAR-2; Par2; proteinase-activated receptor 2; G-protein coupled receptor 11; Protease-activated receptor-2; coagulation factor II receptor-like 1; thrombin receptor-like 1

Santa Cruz Biotechnology
mouse monoclonal (SAM11)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 7a
  • western blot; human; loading ...; fig 1c
Santa Cruz Biotechnology F2rl1 antibody (SantaCruz, SAM11) was used in immunohistochemistry - paraffin section on mouse samples (fig 7a) and in western blot on human samples (fig 1c). Oncotarget (2017) ncbi
mouse monoclonal
  • western blot; human; loading ...; fig 1c
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 7a
Santa Cruz Biotechnology F2rl1 antibody (SantaCruz, SAM11) was used in western blot on human samples (fig 1c) and in immunohistochemistry - paraffin section on mouse samples (fig 7a). Oncotarget (2017) ncbi
mouse monoclonal (SAM11)
  • western blot; human; fig 2b
Santa Cruz Biotechnology F2rl1 antibody (Santa Cruz, sc-13504) was used in western blot on human samples (fig 2b). Front Pharmacol (2016) ncbi
mouse monoclonal (SAM11)
  • flow cytometry; human; 1:100; fig 2 b-e
  • immunohistochemistry; human; fig 1a
  • western blot; human; 1:100; fig 2
Santa Cruz Biotechnology F2rl1 antibody (santa cruz, sc-13504) was used in flow cytometry on human samples at 1:100 (fig 2 b-e), in immunohistochemistry on human samples (fig 1a) and in western blot on human samples at 1:100 (fig 2). J Biol Chem (2016) ncbi
mouse monoclonal (SAM11)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
Santa Cruz Biotechnology F2rl1 antibody (Santa Cruz, sc-13504) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). PLoS ONE (2015) ncbi
mouse monoclonal (SAM11)
  • flow cytometry; human; fig 2
  • immunocytochemistry; human; fig 2
Santa Cruz Biotechnology F2rl1 antibody (Santa Cruz, sc-13504) was used in flow cytometry on human samples (fig 2) and in immunocytochemistry on human samples (fig 2). Physiol Rep (2015) ncbi
mouse monoclonal (SAM11)
  • western blot; human; 1:1000; loading ...; fig 1b
Santa Cruz Biotechnology F2rl1 antibody (Santa Cruz, sc-13504) was used in western blot on human samples at 1:1000 (fig 1b). Cell Death Dis (2014) ncbi
mouse monoclonal (SAM11)
  • immunohistochemistry; mouse; 1:250
  • immunohistochemistry; rat; 1:250
Santa Cruz Biotechnology F2rl1 antibody (Santa Cruz Biotechnology, SC-13504) was used in immunohistochemistry on mouse samples at 1:250 and in immunohistochemistry on rat samples at 1:250. J Comp Neurol (2009) ncbi
Abcam
rabbit polyclonal
  • western blot; human; loading ...; fig 4b
Abcam F2rl1 antibody (Abcam, ab124227) was used in western blot on human samples (fig 4b). Mol Syst Biol (2017) ncbi
EMD Millipore
mouse monoclonal (SAM11)
  • western blot; rat; 1:1000
EMD Millipore F2rl1 antibody (Millipore, MABF243) was used in western blot on rat samples at 1:1000. Mol Pain (2014) ncbi
Articles Reviewed
  1. Nag J, Kancharla A, Maoz M, Turm H, Agranovich D, Gupta C, et al. Low-density lipoprotein receptor-related protein 6 is a novel coreceptor of protease-activated receptor-2 in the dynamics of cancer-associated ?-catenin stabilization. Oncotarget. 2017;8:38650-38667 pubmed publisher
  2. Sokolina K, Kittanakom S, Snider J, Kotlyar M, Maurice P, Gandia J, et al. Systematic protein-protein interaction mapping for clinically relevant human GPCRs. Mol Syst Biol. 2017;13:918 pubmed publisher
  3. Indrakusuma I, Romacho T, Eckel J. Protease-Activated Receptor 2 Promotes Pro-Atherogenic Effects through Transactivation of the VEGF Receptor 2 in Human Vascular Smooth Muscle Cells. Front Pharmacol. 2016;7:497 pubmed publisher
  4. Johnson J, Miller D, Jiang R, Liu Y, Shi Z, Tarwater L, et al. Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma. J Biol Chem. 2016;291:6936-45 pubmed publisher
  5. Lidfeldt J, Bendahl P, Forsare C, Malmström P, Fernö M, Belting M. Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status. PLoS ONE. 2015;10:e0134932 pubmed publisher
  6. Asokananthan N, Lan R, Graham P, Bakker A, Tokanović A, Stewart G. Activation of protease-activated receptors (PARs)-1 and -2 promotes alpha-smooth muscle actin expression and release of cytokines from human lung fibroblasts. Physiol Rep. 2015;3: pubmed publisher
  7. Bao Y, Hou W, Liu R, Gao Y, Kong X, Yang L, et al. PAR2-mediated upregulation of BDNF contributes to central sensitization in bone cancer pain. Mol Pain. 2014;10:28 pubmed publisher
  8. Chen K, Wang C, Tsai M, Wu C, Yang H, Chen L, et al. Interconnections between autophagy and the coagulation cascade in hepatocellular carcinoma. Cell Death Dis. 2014;5:e1244 pubmed publisher
  9. Amadesi S, Grant A, Cottrell G, Vaksman N, Poole D, Rozengurt E, et al. Protein kinase D isoforms are expressed in rat and mouse primary sensory neurons and are activated by agonists of protease-activated receptor 2. J Comp Neurol. 2009;516:141-56 pubmed publisher